The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
The first issue of 2026 features an article exploring the dual journey of a myeloma patient’s treatment alongside the early development of cilta-cel, the CAR-T therapy. Also a letter from Dr. Sagar Lonial and interview with Dr. Valeria Santini.
Rendering this page…
Tap the page to zoom in
Leave feedback about this